SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-044353
Filing Date
2011-08-08
Accepted
2011-08-08 06:04:10
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v230720_10q.htm 10-Q 545873
2 EXHIBIT 31.1 v230720_ex31-1.htm EX-31.1 15660
3 EXHIBIT 31.2 v230720_ex31-2.htm EX-31.2 15601
4 EXHIBIT 32.1 v230720_ex32-1.htm EX-32.1 6466
5 EXHIBIT 32.2 v230720_ex32-2.htm EX-32.2 6600
  Complete submission text file 0001144204-11-044353.txt   1501887

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE plx-20110630.xml EX-101.INS 92567
7 XBRL SCHEMA FILE plx-20110630.xsd EX-101.SCH 11222
8 XBRL CALCULATION FILE plx-20110630_cal.xml EX-101.CAL 27374
9 XBRL DEFINITION FILE plx-20110630_def.xml EX-101.DEF 70806
10 XBRL LABEL FILE plx-20110630_lab.xml EX-101.LAB 83278
11 XBRL PRESENTATION FILE plx-20110630_pre.xml EX-101.PRE 76680
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 111015559
SIC: 2836 Biological Products, (No Diagnostic Substances)